The PCSK9 inhibitor evolocumab seems to robustly reduce LDL cholesterol levels among nearly all treated patients, according to a new analysis of the FOURIER trial. These findings put to bed the notion ...
Fourier analysis provides a powerful framework for decomposing functions into sums or integrals of sinusoidal components, thereby enabling the study of frequency content in signals. In tandem, ...
THOUSAND OAKS, Calif. (Nov. 13, 2020) - Amgen (NASDAQ:AMGN) today announced a new analysis from the Repatha® (evolocumab) cardiovascular (CV) outcomes study (FOURIER) that evaluated the effectiveness ...
Microsoft Office Excel contains a data analysis add-in that allows to to perform a Fourier analysis of a series of numbers. So named for the French mathematician who developed the analytic technique ...
This one (almost) changed my mind about the proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor drugs and the titrate-to-lower-LDL-C-level strategy. My thinking was this: Yes, the ...
Lower may indeed be better, suggests a new analysis of the FOURIER trial addressing outcomes in patients whose LDL cholesterol was brought below 40 mg/dL. The findings, say investigators, support some ...
Experts Issue Caution for Evolocumab Following New Review of FOURIER Data; Amgen Disputes the Claims
Investigators writing in BMJ Open called for “a complete restoration of FOURIER trial data.” Amgen, the maker of evolocumab, said it stood by the data. This article was updated January 5 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results